Boston Chron - Ross Toohey named Managing Director in Chesterfield, Missouri

Trending...

City Of Boston Licensing Board Approves 21 New Liquor Licenses
Mayor Wu Appoints New Commissioners To Boston Civic Design Commission
Boston: Mayor Michelle Wu Joins Federal and State Leaders to Celebrate the Start of Construction of the Redevelopment of the Mary Ellen McCormack Public Housing

NEW YORK - BostonChron -- STS Capital Partners is pleased to announce the appointment of Ross Toohey as a Managing Director. A founder-turned-M&A strategist with a track record of building, scaling, and successfully exiting businesses, Ross brings over two decades of experience across entrepreneurship, corporate development, and strategic advisory. Having led his own company through a premium private equity exit and advised others on both buy- and sell-side transactions, Ross offers a uniquely holistic perspective that enhances STS's ability to deliver Extraordinary Exits™ for founder-led and mid-market companies.

Ross began his entrepreneurial journey as CEO of 2e Group, a privately-owned omnichannel pharma/biotech commercialization agency that he scaled into one of North America's largest independent firms. He spearheaded strategic acquisitions and market expansions, positioning the business as a dominant industry force and securing an elite roster of Fortune 100 clients.

More on Boston Chron

In 2019, Ross led the successful sale of 2e Group to medical communications leader Fishawack Health (now Avalere Health). Post-acquisition, he was appointed Chief Commercial Officer, overseeing corporate business development and M&A. During his tenure, Ross pioneered the now-ubiquitous concept of fully integrated pharma commercialization, helping drive the company's growth to over $1.1 billion in enterprise value.

Following his success in corporate M&A, Ross founded EONOVA, an exit planning and advisory firm. Through EONOVA, he leverages his expertise in leadership, strategic growth, and both buy- and sell-side M&A to help business owners identify valuation gaps, plan successful exits, and accelerate enterprise value. He is a sought-after strategic growth consultant, particularly for businesses in healthtech, pharma/biotech, and professional services.

Ross is a Certified Exit Planning Advisor (CEPA) and serves as Mid-Americas U.S. Regional Board Chairman-Elect for the Young Presidents' Organization (YPO).

More on Boston Chron

"Ross has sat in the founder's seat, scaled a business into a market leader, and achieved a premium exit. Now, as an STS Managing Director, he draws on that firsthand experience to help our clients do the same – maximizing value and creating extraordinary outcomes," said Sean Friday, CEO of STS Capital Partners.

About STS Capital Partners:

STS Capital Partners is a global sell-side M&A firm like no other. We are expert guides for private, founder, and entrepreneurial business owners on the journey to achieving an Extraordinary Exit™. Our extensive global relationships, world-class team, and proven deal process bring international strategic buyers and investors to the table who deliver maximum financial value. As a result, we help clients fulfill bigger ambitions in life and leave lasting legacies by inspiring charitable donations through our Success to Significance™ program with a goal of raising billions of dollars in new philanthropic and impact capital to support charities like Altruvest, Knowledge Impact Network, and DignityMoves.